<< Back to introduction page

Research & Development

Research

Evaluation of tumor mimetic cell surface (TMCS) antigen in detection of cancer.

Development

ANTI-TMCS TEST

A rapid visual test for the qualitative screening of lymphocytes sensitized to tumor antigens.

Biotron Diagnostics Inc. California and BioConfirming Inc., North Carolina are engaged in
in early product development, pre-clinical & clinical research leading to developing genetic and point-of-care biomarker detection technology for personalized medicine.